Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. (NY: OGN )

14.89 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organon & Co.

< Previous 1 2 3 4 5 6 7 8 9 Next >
7 Growth Stocks That Are Trading at a Bargain Price
Some analysts suggest that equities are in the beginning of a bull market. If so, now is a good time to look at buying bargain growth stocks. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
Via Benzinga
Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
From Organon & Co.
Via Business Wire
Organon: Dividend Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's morning session saw 84 companies set new 52-week lows. 
Via Benzinga
Why Shares of Organon Fell 15% Thursday
The company reported fourth-quarter and year-end financials. 
Via The Motley Fool
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
Earnings Preview For Organon
Via Benzinga
Organon Reports Better Than Expected Q3 Earnings
Via Benzinga
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022
From Organon
Via Business Wire
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023
From Organon & Co.
Via Business Wire
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
Amgen launched its biosimilar knockoff on Tuesday at a steep discount. 
Via Investor's Business Daily
'It's The Only China Stock I'd Buy': Cramer On This E-Commerce Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Alibaba Group Holding Limited (NYSE: BABA) is the only China stock he would buy. 
Via Benzinga
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
Organon sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
From Organon & Co.
Via Business Wire
Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference
From Organon & Co.
Via Business Wire
Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
From Organon & Co.
Via Business Wire
3 Dow Stocks to Take Seriously in 2023
The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings. 
Via InvestorPlace
'FTX Users May Seek DeFi Alternatives,' Interview With Origin Protocol's Andra Nicolau
In a risk-off environment where cryptocurrency has plummeted to a fraction of its previous valuation, it’s no secret raising capital in 2022 has become a challenge for startups and industry behemoths... 
Via Benzinga
Organon To Present at the Piper Sandler 34th Annual Healthcare Conference
From Organon & Co.
Via Business Wire
10 Spin-Off Stocks That Pay Dividends
10 spin-offs from recent years that now pay dividends after being separated from their parent companies. 
Via Talk Markets
Recap: Organon Q3 Earnings
Organon (NYSE:OGN) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Organon beat estimated earnings by... 
Via Benzinga
Organon Reports Results for the Third Quarter Ended September 30, 2022
From Organon & Co.
Via Business Wire
Looking Into Organon's Recent Short Interest
Organon's (NYSE:OGN) short percent of float has fallen 4.48% since its last report. The company recently reported that it has 5.78 million shares sold short, which is 2.56% of all regular shares that... 
Via Benzinga
Origin Protocol Building DeFi & NFTs In The Bear: Interview With Co-Founder Joshua Fraser
Blockchain startups raised an aggregate of billions of dollars through the bull market, but it’s no secret those days are at least temporarily halted. For most DeFi protocols and almost every NFT... 
Via Benzinga
Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022
From Organon & Co.
Via Business Wire
Beat the Dow Jones With This Unstoppable Dividend Stock
This pharmaceutical stock combines strong financials with an above-average dividend. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.